TY - JOUR
T1 - Clinical significance of CD7‐positive stem cell leukemia. A distinct subtype of mixed lineage leukemia
AU - Yumura‐Yagi, Keiko
AU - Hara, Junichi
AU - Kurahashi, Hiroki
AU - Okamura, Jun
AU - Koizumi, Shoichi
AU - Toyoda, Yasunori
AU - Murayama, Norihide
AU - Inoue, Masami
AU - Ishihara, Shigehiko
AU - Tawa, Akio
AU - Nishiura, Tetsuo
AU - Kaneyama, Yoshio
AU - Okada, Shintaro
AU - Kawa‐Ha, Keisei
PY - 1991/11/15
Y1 - 1991/11/15
N2 - Ten leukemia cases with mixed phenotype were investigated in terms of clinical characteristics and cellular origin. Three patients were infants and six patients were older children. Six of them had a high leukocyte count and a mediastinal mass was found in three cases. All but one showed hepatosplenomegaly and/or lymphoadenopathy. In spite of intensive chemotherapy, most of them responded poorly. Cytochemical analysis of their leukemic cells revealed a low percentage of positivity for myeloperoxidase reactivity (< 25%) in two cases and electron microscopic platelet peroxidase reactivity was found in one of three analyzed cases. Phenotypically, these cells all expressed CD7, and other T‐lineage‐associated, B‐lineage‐associated, and/or myeloid‐associated antigens were also detected to some extent. In addition, three cases expressed CD41 and one case expressed CD56. The T‐cell receptor (TCR) genes and immunoglobulin gene were in the germline configuration in seven cases. In three rearranged cases two showed only the TCR‐δ gene rearrangement, and one had both TCR‐γ and δ gene rearrangements. Cell culture studies with 12–0‐tetradecanoyl‐phorbol‐13‐acetate (TPA) revealed differentiation to the T‐lineage in two cases and to a myeloid lineage in one case. Megakaryocytic differentiation was detected in two cases in culture without TPA. These results suggest that the cells from these cases arose from stem cells capable of both lymphoid and nonlymphoid differentiation. Although the cells were heterogeneous with regard to their potency of differentiation, they have similar clinical characteristics. Because of poor prognosis, it is important to identify this type of leukemia, and allogenic or autologous bone marrow transplantation should be considered. Cancer 68:2273–2280, 1991.
AB - Ten leukemia cases with mixed phenotype were investigated in terms of clinical characteristics and cellular origin. Three patients were infants and six patients were older children. Six of them had a high leukocyte count and a mediastinal mass was found in three cases. All but one showed hepatosplenomegaly and/or lymphoadenopathy. In spite of intensive chemotherapy, most of them responded poorly. Cytochemical analysis of their leukemic cells revealed a low percentage of positivity for myeloperoxidase reactivity (< 25%) in two cases and electron microscopic platelet peroxidase reactivity was found in one of three analyzed cases. Phenotypically, these cells all expressed CD7, and other T‐lineage‐associated, B‐lineage‐associated, and/or myeloid‐associated antigens were also detected to some extent. In addition, three cases expressed CD41 and one case expressed CD56. The T‐cell receptor (TCR) genes and immunoglobulin gene were in the germline configuration in seven cases. In three rearranged cases two showed only the TCR‐δ gene rearrangement, and one had both TCR‐γ and δ gene rearrangements. Cell culture studies with 12–0‐tetradecanoyl‐phorbol‐13‐acetate (TPA) revealed differentiation to the T‐lineage in two cases and to a myeloid lineage in one case. Megakaryocytic differentiation was detected in two cases in culture without TPA. These results suggest that the cells from these cases arose from stem cells capable of both lymphoid and nonlymphoid differentiation. Although the cells were heterogeneous with regard to their potency of differentiation, they have similar clinical characteristics. Because of poor prognosis, it is important to identify this type of leukemia, and allogenic or autologous bone marrow transplantation should be considered. Cancer 68:2273–2280, 1991.
UR - http://www.scopus.com/inward/record.url?scp=0025948947&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025948947&partnerID=8YFLogxK
U2 - 10.1002/1097-0142(19911115)68:10<2273::AID-CNCR2820681028>3.0.CO;2-G
DO - 10.1002/1097-0142(19911115)68:10<2273::AID-CNCR2820681028>3.0.CO;2-G
M3 - Article
C2 - 1717122
AN - SCOPUS:0025948947
SN - 0008-543X
VL - 68
SP - 2273
EP - 2280
JO - Cancer
JF - Cancer
IS - 10
ER -